Simpson Thacher recently represented Teleflex Incorporated (“Teleflex”) in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 5.875% Senior Notes due 2032. Teleflex intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its outstanding 4.625% Senior Notes due 2027 (the “2027 Notes”).
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Teleflex is the home of Arrow®, Barrigel®, Deknatel®, LMA®, Pilling®, QuikClot®, Rusch®, UroLift® and Weck® - trusted brands united by a common sense of purpose.
The Simpson Thacher team for this transaction included Roxane Reardon, Matt Hart, Andrew Scattergood and Erin Vogt (Capital Markets); Jon Cantor (Tax); Gillian Moldowan, Ashlie Lawton, Sara Mazurek and Skyler Kanfer (ECEB); Ron Ben-Yehuda, Sara Liu and Christian Bond (IP); and Vanessa Burrows, Alison Peters and Jacob Madden (Healthcare).